BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 06/11/2014

FDA Releases Draft Guidance on Bioequivalence Recommendations for Concerta Extended-Release Tablets

The FDA has made available a draft guidance for industry that provides specific recommendations for designing bioequivalence studies to support abbreviated new drug applications referencing Concerta, a medication used to treat attention deficit hyperactivity disorder (ADHD).

Source: Federal Register — Food and Drug AdministrationOpen original release →